The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910).
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Takeda
Research Funding - Dainippon Sumitomo Pharma (Inst); NanoCarrier (Inst)
 
Yasuhiro Shimada
Honoraria - Bayer; Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Chugai Pharma (Inst); Lilly Japan (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Junki Mizusawa
Honoraria - Chugai Pharma
 
Yusuke Kinugasa
Honoraria - Bayer; Chugai Pharma; Covidien; Japan Medical; Johnson & Johnson; Stryker; Taiho Pharmaceutical; Takeda
Research Funding - Yakult Pharmaceutical
 
Yukihide Kanemitsu
Honoraria - Asahi Kasei; Chugai Pharma; Covidien; Taiho Pharmaceutical; Takeda
Research Funding - Kawasumi Laboratories (Inst); TERUMO (Inst)
 
Masayuki Ohue
No Relationships to Disclose
 
Shoichi Fujii
No Relationships to Disclose
 
Nobuhiro Takiguchi
No Relationships to Disclose
 
Toshimasa Yatsuoka
Honoraria - Covidien; Taiho Pharmaceutical
 
Yasumasa Takii
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Kaken Pharmaceutical; Merck Serono; Taiho Pharmaceutical; Takeda
 
Hitoshi Ojima
No Relationships to Disclose
 
Hiroyuki Masuko
No Relationships to Disclose
 
Yoshiro Kubo
Honoraria - Yakult Pharmaceutical
 
Hideyuki Mishima
Honoraria - Chugai Pharma; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Pharmaceutical (Inst)
 
Takashi Yamaguchi
No Relationships to Disclose
 
HIroyuki Bandou
No Relationships to Disclose
 
Toshihiko Sato
No Relationships to Disclose
 
Takeshi Kato
Honoraria - Bayer; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Chugai Pharma (Inst)
 
Kenichi Nakamura
Honoraria - Daiichi Sankyo; Lilly; Taiho Pharmaceutical; Takeda
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Nippon Boehringer Ingelheim; Novartis; Taiho Pharmaceutical